APC/Cyanine7 Anti-Mouse CD25 Antibody
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Mouse CD25 Antibody(克隆 PC61.5.3) 为大鼠源 IgG1 单克隆抗体,靶向 IL-2 receptor α chain(别名 Low affinity IL-2R 等),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,340 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 APC/Cyanine7 Anti-Mouse CD25 Antibody(克隆 PC61.5.3) 为大鼠源 IgG1 单克隆抗体,靶向 IL-2 receptor α chain(别名 Low affinity IL-2R 等),APC/Cyanine7 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,340 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
206711 | 25 μg | ¥1,340
206712 | 100 μg | ¥3,390
Product Details
Regulatory Status|RUO
Protein Concentration|0.2 mg/mL
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.2 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. iF488 has an excitation max at 491 nm and an emission max at 516 nm.
See All Formats|Clone PC61.5.3
Background Information
CD25, also known as the interleukin-2 receptor alpha chain (IL-2Rα), is a transmembrane glycoprotein that plays a central role in regulating immune responses. It functions as part of the interleukin-2 (IL-2) receptor complex, which is essential for T cell proliferation, survival, and differentiation. CD25 itself has low affinity for IL-2 when expressed alone, but when combined with IL-2 receptor beta (CD122) and the common gamma chain (CD132), it forms the high-affinity IL-2 receptor complex capable of effective signal transduction.
Structurally, CD25 is a single-pass type I membrane protein composed of an extracellular domain of approximately 219 amino acids responsible for IL-2 binding, a hydrophobic transmembrane segment, and a short cytoplasmic tail that lacks intrinsic signaling domains. The extracellular region is heavily glycosylated, which stabilizes its conformation and facilitates ligand interaction. Because the alpha chain alone is not signaling-competent, it acts primarily to increase the receptor complex’s affinity for IL-2 and to expand the range of cells responsive to low cytokine concentrations.
CD25’s main ligand, IL-2, is a cytokine crucial for T lymphocyte expansion and immune tolerance. Engagement of IL-2 with the high-affinity receptor triggers the JAK-STAT signaling pathway, leading to cell proliferation, differentiation, and regulatory T cell (Treg) function. CD25 is constitutively expressed on Tregs and upregulated on activated CD4+ and CD8+ T cells, making it a marker of immune activation as well as immune regulation.
Aberrant CD25 expression or IL-2 signaling contributes to immune dysregulation and disease. In autoimmune disorders such as multiple sclerosis and type 1 diabetes, alterations in the IL-2/CD25 axis impair Treg function and tolerance mechanisms. Elevated CD25 expression is also found in certain malignancies, particularly adult T-cell leukemia/lymphoma and Hodgkin lymphoma, where it may serve as a biomarker of malignant proliferation. Moreover, soluble CD25, released from cell surfaces, can act as a decoy receptor, modulating IL-2 availability and contributing to immune suppression in cancer and chronic inflammation.
Therapeutically, CD25 is a prominent target for immune modulation. Monoclonal antibodies such as basiliximab and daclizumab have been developed to block IL-2 binding, preventing T cell activation and mitigating graft rejection in organ transplantation. Conversely, IL-2 or CD25-targeted therapies that enhance regulatory T cell function are being explored to treat autoimmune diseases and promote immune tolerance. Thus, CD25 remains a critical immunological node, balancing activation and regulation within the immune system.
Data Sheets
C57BL/6 Mouse splenocytes stimulated with Anti-Mouse CD3/CD28 for 2-days were stained with APC/Cyanine7 Anti-Mouse CD25 clone PC61.5.3 (color-filled histogram) or an isotype control (gray histogram).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). APC/Cyanine7 Anti-Mouse CD25 Antibody(206711)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-cd25-antibody.html.
TeleVM. (2026, November 12). APC/Cyanine7 Anti-Mouse CD25 Antibody(206711). 产品目录. https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-cd25-antibody.html
@misc{biocsp_item_apc_cyanine7_anti_mouse_cd25_antibody,
title = {APC/Cyanine7 Anti-Mouse CD25 Antibody(206711)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/apc-cyanine7-anti-mouse-cd25-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源